CONSOLIDATED FINANCIAL STATEMENTS Reclassifications as a Result of the Merger with DuPont (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Business Acquisition [Line Items]
Cost of sales	$ 10,666	$ 9,840	$ 31,626	$ 27,066
Selling, general and administrative expenses	723	738	2,201	2,166
Integration and separation costs		127		228
Sundry income (expense) - net	268	22	144	1,369
Interest income	27	0	74	0
Accounts and notes receivable - Other					$ 4,312
Other current assets	773		773		711
Other	2,988		2,988		2,097
Dividends payable					0
Accrued and other current liabilities	$ 5,373		5,373		4,481
Net periodic pension benefit cost			334	312
Net gain on sales of assets, businesses and investments			(474)	(179)
Net gain on sales of investments				0
Net gain on sales of property, businesses and consolidated companies				0
Other net loss			296	300
Accounts payable			1,207	1,031
Other assets and liabilities - net 1			233	(331)
Transaction financing, debt issuance and other costs				0
Other financing activities - net			0	(2)
Dividend equivalents on participating securities				0
Stockholders' Equity, Other			$ (23)	(21)
Scenario, Previously Reported [Member]
Business Acquisition [Line Items]
Cost of sales		9,841		27,067
Selling, general and administrative expenses		864		2,393
Integration and separation costs		0		0
Sundry income (expense) - net		(4)		1,305
Interest income		$ 26		64
Accounts and notes receivable - Other					4,358
Other current assets					665
Other					2,401
Dividends payable					508
Accrued and other current liabilities					$ 3,669
Net periodic pension benefit cost				0
Net gain on sales of assets, businesses and investments				0
Net gain on sales of investments				(97)
Net gain on sales of property, businesses and consolidated companies				(82)
Other net loss				(97)
Accounts payable				695
Other assets and liabilities - net 1				(520)
Transaction financing, debt issuance and other costs				(2)
Other financing activities - net				0
Dividend equivalents on participating securities				(21)
Stockholders' Equity, Other				$ 0